Atoltivimab

Tax included
Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection.
MedChemExpress 
HY-P99343

Data sheet

Size
Multiple sizes
Reactivity
Filovirus
Application
COVID-19-anti-virus
CAS
2135632-29-8